Schrödinger (Nasdaq: SDGR) has halted the clinical development of its oral drug SGR-2921 following the occurrence of two ...

US President Donald Trump issued an executive order on August 13 2025 instructing the Department of Health and Human Services ...

A first-of-its-kind study from UK pharm major AstraZeneca and Macmillan Cancer Support into the barriers around access to the ...

With help from artificial intelligence, Massachusetts Institute of Technology (MIT) researchers have designed novel ...

Eli Lilly (NYSE: LLY) has entered into a collaboration with Boston-based Superluminal Medicines to develop small-molecule ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for AstraZeneca’s ...

Danish clinical-stage techbio, Evaxion, which is specializing in developing AI-Immunology powered vaccines, today provided a ...

Pilatus Biosciences, a US biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and ...

China-based RNA therapeutics developer Ribopeutic has raised close to 100 million yuan ($13.9 million) in pre-A financing, ...

Shares of Israel-based Nasus Pharma rose 7.6% to $8.88 in after-hours activity yesterday after it announced the pricing of ...

US biotech Response Pharmaceuticals (Nasdaq: RSPN) has unveiled top-line Phase II results for its experimental obesity ...

Danish CNS specialist Lundbeck has reported revenue grew 14% at constant exchange rates (CER), plus 14% DKK, to 12,258 ...